Strumento inattivo

Azioni PAREXEL International Corporation

Azioni

Durata

Periodo

Stile

Parexel : Launches Enhanced Integrated Functional Service Provider Model to Drive Delivery of Innovative Clinical Research Partnerships	23/06/19
PAREXEL International : Launches Perceptive® Cloud for the Life Sciences Industry	12/12/17
PAREXEL International : Expands Global Regulatory Services with Addition of Senior Executives from FDA and Oncology Industry	15/11/17
PAREXEL International : Pamplona Capital Management Completes Acquisition of PAREXEL International	29/09/17
PAREXEL International : Receives Shareholder Approval for Proposed Acquisition by Pamplona Capital Management	18/09/17

Dirigenti	Titolo	Età	Da
Duncan MacDonald CEO	Chief Executive Officer	56	-
Gregory Rush DFI	Director of Finance/CFO	56	-
Amy McKee CTO	Chief Tech/Sci/R&D Officer	52	01/01/19

Amministratori	Titolo	Età	Da
Sherilyn McCoy CHM	Chairman	65	-
Duncan MacDonald CEO	Chief Executive Officer	56	-
May Kin Ho BRD	Director/Board Member	71	26/08/15

Settore

	Variaz. 1 gen.	Capi.
IQVIA HOLDINGS INC.	-1,42%	41,35 Mrd
LONZA GROUP AG	+42,15%	40,38 Mrd
MODERNA, INC.	+1,97%	39,05 Mrd
CELLTRION, INC.	-14,19%	26,67 Mrd
ICON PUBLIC LIMITED COMPANY	+1,82%	24,07 Mrd
ALNYLAM PHARMACEUTICALS, INC.	-24,55%	18,36 Mrd
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-4,07%	11,68 Mrd
MEDPACE HOLDINGS, INC.	+21,36%	11,6 Mrd
UNITED THERAPEUTICS CORPORATION	+8,20%	11,15 Mrd